Crovalimab (Anti-Complement C5)
Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2812 |
| Sku # | A2812-1mg*25 |
| Pricing | 1mg*25, $5070.00 |